Maxwell Finland lecture: viral vaccines and their ways.
D000914:Antibodies, Viral; D000917:Antibody Formation; D002648:Child; D005260:Female; D006801:Humans; D007109:Immunity; D011051:Poliomyelitis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects / Q000276:immunology; D011055:Poliovirus Vaccine, Oral; D012409:Rubella / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D012411:Rubella Vaccine / Q000276:immunology; D014481:United States; D014611:Vaccination; D014613:Vaccines, Attenuated
D000914:Antibodies, Viral; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated